AC8
Click for more information
0.00% 4.0¢ auscann group holdings ltd

There is a fast growing business of prescribed medicinal...

  1. sidage
    691 Posts.
    lightbulb Created with Sketch. 160
    clock Created with Sketch.
    23/03/20
    19:12
    Post #: 43654288
    There is a fast growing business of prescribed medicinal cannabis in Australia. it's currently around 3600 patients per month and the average spend is about $300.

    that means there is $1m spent on cannabis per month.

    This could be a great revenue opportunity for Auscann to sell their new hard shell cannabis pills on this via the Special Access Scheme.

    What is stopping them from participating?
    AC8 Price at posting: 15.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.62M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AC8 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.